Active Ingredient History

NOW
  • Now
Vatalanib is a small molecule protein kinase inhibitor that inhibits angiogenesis. It is being studied as a possible treatment for several types of cancer, particularly cancer that is at an advanced stage or has not responded to chemotherapy. Vatalanib is orally active, that is, it is effective when taken by mouth.   Wikipedia

  • SMILES: Clc1ccc(Nc2nnc(Cc3ccncc3)c4ccccc24)cc1
  • InChIKey: YCOYDOIWSSHVCK-UHFFFAOYSA-N
  • Mol. Mass: 346.82
  • ALogP: 5.01
  • ChEMBL Molecule:
More Chemistry
1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine succinate | 1-(4-chloroanilino)-4-(pyridylmethyl)phthalazine | 1-(4-chloroanilino)-(4-pyridylmethyl)phthalazine dihydrochloride | 1-(4-chloroanilino)-4-(pyridylmethyl)phthalazine dihydrochloride | bay-86-5127 | cgp-79787 | cgp 797870 | cgp-797870 | k-222584 | nvp-ptk787 | ptk787 | ptk 787 | ptk-787 | ptk/zk | vatalanib | vatalinib | zk222584 | zk 222584 | zk-222584 | zk232934 | zk 232934 | zk-232934

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue